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the cost of 3 strategies: 1) axillary lymph node dissection; 2) sentinel lymph node
biopsy followed by distant axillary lymph node dissection in case of positive sen-
tinel lymph node; and and 3) sentinel lymph node biopsy with intra-operative
histological examination and axillary lymph node dissection for positive cases. A
multivariate probabilistic sensitivity analysis was conducted on identification rate,
complication rates, sensitivity, specificity and length of hospital stay. RESULTS:
The sentinel mph node biopsy is less costly than lyaxillary lymph node dissection
in the early stages of breast cancer. Intra-operative histological examination of
sentinel lymph node significantly reduces the cost of the procedure. Data on mo-
lecular intra-operative examination couldn’t be integrated in the present study as
no French cost data were available. In a systematic review, no survival difference
could be demonstrated between the three strategies in early stage of breast cancer
and quality of life was found to be better with sentinel lymph node biopsy than
with axillary lymph node dissection. Nevertheless, more data are needed to inte-
grate these results in a cost-effectiveness analysis. CONCLUSIONS: The study con-
firms the interest of sentinel lymph node biopsy in early stage of breast cancer. The
cost comparison helps to determine the choice of the intervention alongside other
arguments as women’s preference, efficacy and safety.
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OBJECTIVES: The advent of robotic surgery to prostate cancer treatment has been
justified by improved convalescence, fewer medical complications and decreased
morbidity in comparison with traditional operating techniques. Furthermore, ro-
botic surgery has been claimed to achieve better results concerning urinary conti-
nence and sexual factors. Our aim was to find out whether these claims are realized
in an unselected material of a large university hospital. METHODS: An ongoing
observational follow-up study in the real-world setting of a university hospital
using the 15D generic health-related quality of life (HRQoL) instrument. Patients
entering for treatment of prostate cancer were asked to fill in the HRQoL question-
naire at baseline and 3, 6, 12 and 24 months after entering treatment. RESULTS: So
far, 123 patients have undergone surgery: 76 in the robot-assisted laparoscopic
prostatectomy group (RALP, mean age 60.6 years) and 47 in the open surgery group
(OS, mean age 61.5 years). The baseline prognostic Gleason score did not differ in a
statistically significant manner between the groups (6.91 vs. 6.98, p0.593). The
mean HRQoL score in the OS group was slightly lower at baseline than that in the
RALP group (0.940 vs. 0.920), but the difference was not statistically significant.
During the two-year follow-up the HRQoL score remained slightly lower in the OS
group at all follow-up points, but none of the differences was statistically signifi-
cant. At the three-month follow-up the RALP group fared statistically significantly
better on the dimensions of “excretion” (p0.05) and “sexual activity” (p0.01), but
at the subsequent follow-up points the statistically significant difference had dis-
appeared. The dimension of “vitality” did not differ between the groups at any of
the follow-up points. CONCLUSIONS: The benefit from robot-assisted prostate sur-
gery was in our material so small that it probably does not offset the high cost
associated with the robotic approach.
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OBJECTIVES: Immediate or early breast reconstruction (BR) a viable option for the
majority of women with breast cancer. However, only 5.6% of the mastectomy
patients underwent BR in Taiwan. Quantitative evidence on the preferences of
women for BR is limited; this study, therefore, elicits such preferences. METHODS:
Face to face patient interviews were conducted on 156 women who had previously
undergone a therapeutic mastectomy, of whom 60 had also undergone a BR. These
women were asked to choose between hypothetical BR profiles featuring six attri-
butes: (1) material used for reconstruction, (2) number and duration of operations,
(3) failure rate, (4) aesthetic result and (5) out-of-pocket payment (in NT$), and
additionally had the option to choose not to undergo BR. The relative importance of
attributes and trade-offs that the patients were willing to make among them were
examined using a conditional logit regression model. RESULTS: Coefficients for all
treatment attributes were significant with a prior expected direction. Women had
a significant positive preference for autologous tissues, shorter operations, ‘excel-
lent’ aesthetic results, a reduction in failure rate and in out-of-pocket payments.
Expected 1% reductions in the chance of failure were associated with a willingness
to pay of $NT40,000. Women would be willing to pay NT$22,000 to replace implants
with autologous tissues, NT$81,000 to reduce operation time from 8 hours to 2
hours, and NT$86,000 to increase the aesthetic result from ‘excellent’ to
‘moderate’. CONCLUSIONS: These findings provide insight into how BR are viewed
and valued by women, and how future advances in surgical techniques will in-
crease the uptake of BR by meeting women’s preferences for reduction in length of
time of operations and failure rate, as well as improvement in aesthetic results.
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OBJECTIVES: The collection of pre- and post-operative Patient Reported Outcome
(PROs) have traditionally been used to assess the benefit of medical and surgical
interventions. More recently, individual patient level PROs have been used in ev-
eryday clinical practice. Online website ‘electronic’ collection, so called remote
ePROs, provides a platform to collect scores at regular intervals and report results
back to both patients and their clinicians. Chronic conditions can then be moni-
tored over time to compare the response to treatment with that of other patients.
The primary aim of this study was to assess whether scores collected electronically
via an online internet website (ePROs) are equivalent to scores collected via the
traditional pen and paper format (PROs). METHODS: A group of 47 patients, who
had previously undergone open hip debridement for femeroacetabular impinge-
ment, were allocated to one of two groups as part of a randomized crossover study.
As per the ‘International Society for Pharmacoeconomics and Outcomes Research
(ISPOR) ePRO Good Research Practices Task Force Report’, this study was powered
to rule out a difference between PRO and ePRO assessment of 0.3 standard devia-
tions. Group 1 completed the online ePRO scores- Oxford, McCarthy, UCLA and
HowRu score- followed by the PRO paper equivalents one week later, and Group 2
completed the scores in reverse order.RESULTS:The difference between the online
ePRO and paper PRO Oxford score in Group 1 was 1.6, 0.9 to 2.4 (mean, 95% confi-
dence interval (CI)) and in Group 2 was 0.8, 0.2 to 1.3 (mean, 95% CI). There was no
significant difference between Group 1 and Group 2. Therefore analysis revealed an
ePRO Oxford score of 32.8, 29.7 to 35.8 (mean, 95% CI) and a PRO score of 33.0, 29.9
to 36.1 (mean, 95% CI). CONCLUSIONS: Remote online ePRO score collection using
this website is equivalent to paper PRO collection.
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OBJECTIVES: Vertebral compression fractures (VCFs) are a fairly common and
painful result of cancer but little is known about the quality of life (QoL) in these
patients. The randomised controlled trial (RCT) CAFE, comparing balloon kyphop-
lasty (BKP) to non-surgical management (NSM), is the only RCT that has been
conducted in cancer patients with VCFs. The objective of this study was to use data
from CAFE to analyse QoL in cancer patients with VCFs and to analyse the impact
of BKP on QoL in these patients. METHODS: SF-36 data from the CAFE study were
analysed. Answers to the SF-36 questionnaire were translated into eight subcate-
gories which in turn were mapped to health utilities. At baseline, complete data
were available for 55 patients in the control group 65 patients in the treatment
group; both groups had lost seven at 1 month’s follow-up. Although the original
study ran for 12 months, high crossover rates from control group to treatment after
1 month posed a challenge to an analysis of long-term QoL effects. RESULTS: At
baseline, the NSM group had a mean utility (SE) of 0.27 (0.027) while the BKP group
had 0.30 (0.027). After 1 month, the NSM group had a utility of 0.30 (0.030) and the
BKP group 0.63 (0.029). The difference in utility at 1 month (0.33) was statistically
significant (p0.001). No significant differences in baseline QoL or QoL impact of
BKP were observed between different underlying cancer types. . Health utilities
appeared to be relatively stable between 1 month and 12 months. CONCLUSIONS:
VCFs in cancer patients are associated with significant QoL impairment. QoL is
meaningfully improved by treating painful VCFs with BKP, independently of the
underlying cancer type. This information can be used as a basis for further re-
search, such as analyses of the cost-effectiveness of BKP.
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OBJECTIVES: Liver transplantation (LTx) is indicated in familial amyloid polyneuropathy
(FAP) to prevent long term disease progression. This study aims to assess health-related
quality of life (HRQoL) in FAP patients before and after LTx. METHODS: A systematic
review was conducted by January 2012 through Cochrane Collaboration, Medline,
EMBASE, and Lilacs databases. Outcome measures were mental and physical di-
mensions assessed by HRQoL questionnaires. RESULTS: Five studies met eligibility
criteria. Before LTx, FAP patients presented lower scores measured by EuroQol
(EQ-5D) index when compared to general population (18-34 years: 0.810.02; 35-49
years: 0.680.03; 50-64 years: 0.570.04; 65 years: 0.580.05 versus 0.920.00;
0.880.00; 0.840,00, and 0.790,00, respectively; p0.0001 for all comparisons).
When compared to other chronic diseases, FAP presented a significantly worse
HRQoL (FAP[50-64 years]: 0.58; diabetes: 0.76; stroke: 0.69; emphysema: 0.68; heart
failure: 0.64; rheumatoid arthritis: 0.66; p 0.0001 for all comparisons). After LTx,
HRQoL assessed by Short Form Health Survey (SF-36) was lower in FAP when com-
pared to non-PAF transplanted patients (p0.04). Physical and emotional well-
being domains 4 years after transplantation were significantly lower compared to
non-FAP transplanted (physical:35%-75%; emotional: 24%-54% reduction) and gen-
eral population (physical:16%-55%, emotional: 10%-39% reduction). A new score
was developed to measure the difference between HRQoL at 6 months after and
A406 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 7 7 – A 5 7 5
